Table 1 |
|||
|
Baseline and follow-up characteristics of participants |
|||
|
Characteristic |
Survivors (n = 158) |
||
|
|
|||
|
Transfused |
Not transfused |
P |
|
|
|
|||
|
N (%) |
61 (39) |
97(61) |
|
|
|
|||
|
Age in months (median, IQR) |
24(14–35) |
31(21–43) |
0.001 |
|
|
|||
|
Proportion < 24 months (%) |
24 |
48 |
0.002 |
|
|
|||
|
Male sex (n, %) |
30(49) |
52(57) |
0.59 |
|
|
|||
|
Admission duration (days) (median, IQR) |
5(4–8) |
4(3–6) |
0.13 |
|
|
|||
|
Review interval (days) (median, IQR) |
28 (25–31) |
28(27–31) |
0.88 |
|
|
|||
|
Respiratory distress (n, %) |
46(76) |
54(56) |
0.001 |
|
|
|||
|
Lactate (mmol/L, mean SD) |
5.8(4.5) |
4.8(3.7) |
0.06 |
|
|
|||
|
Hypoglycaemia (<2.2 mmol/L) (n, %) |
10(16) |
21(22) |
0.239 |
|
|
|||
|
Severe acidosis (Base deficit >15) (n, %) |
37(60) |
45(46) |
0.03 |
|
|
|||
|
Haematological variables |
|||
|
|
|||
|
Admission Hb (mean, SD) |
5.0 (1.9) |
8.3(1.7) |
0.001 |
|
|
|||
|
MCV (mean, SD) |
75.6(6.3) |
74.2(6.8) |
0.09 |
|
|
|||
|
MUAC (mean, SD) |
13.8(1.3) |
14.4(1.5) |
0.02 |
|
|
|||
|
Discharge Hb (mean, SD) |
6.4 (1.5) |
6.8(1.6) |
0.08 |
|
|
|||
|
Follow-up Hb (mean, SD) |
10.2(1.7) |
10.0(1.3) |
0.25 |
|
|
|||
|
Akech et al. Malaria Journal 2008 7:256 doi:10.1186/1475-2875-7-256 |
|||
